This project investigates therapeutic genome editing for Krabbe disease using in vivo prime editing. Genomic and transcriptomic sequencing data were generated from treated and control samples to evaluate editing efficiency, molecular correction of the disease-causing mutation, and therapeutic outcomes following genome editing intervention.
